文献速递运动医学关节外科

无创伤性肩袖撕裂中脂肪肌肉变性的进展

Progression of Fatty Muscle Degeneration in Atraumatic Rotator Cuff Tears.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

这项前瞻性队列研究纳入一侧无症状肩袖撕裂、对侧因肩袖疾病疼痛的患者,每年行肩部超声评估撕裂大小、位置及脂肪肌肉变性,中位随访至少2年。结果显示,基线撕裂较大、随访中撕裂扩大的肩袖更易出现脂肪肌肉变性进展,且撕裂扩大后脂肪变性进展较快;证据等级为预后II级。

要点

  • 基线撕裂越大,脂肪肌肉变性进展风险越高。
  • 随访中撕裂扩大者脂肪变性进展更常见(43%比20%)。
  • 撕裂扩大后脂肪变性进展中位时间约1年。

核心结论

  • 脂肪肌肉变性进展在基线撕裂较大、随时间扩大且扩大幅度较大的撕裂中更常见。
  • 研究结果提示,在某些退变性肩袖撕裂中,肌肉变性常快速进展,与撕裂大小的临床相关增加有关。

研究设计与样本

  • 前瞻性队列研究,纳入一侧无症状肩袖撕裂、对侧因肩袖疾病疼痛的患者。
  • 每年行肩部超声评估撕裂大小、位置和脂肪肌肉变性,要求至少随访2年。
  • 共156肩全层肩袖撕裂可能符合条件,其中70肩在某个时间点至少1块肩袖肌肉存在可测量的脂肪肌肉变性。

主要发现

  • 脂肪变性肩与无变性肩相比,患者年龄更大(均值65.8岁[95%CI 64.0至67.6]比61.0岁[95%CI 59.1至62.9],p<0.05)。
  • 基线撕裂中位大小在脂肪变性肩大于无变性肩(宽13 mm比10 mm,长13 mm比10 mm,p<0.05)。
  • 脂肪变性撕裂随访中更易扩大(79%比58%;OR 2.64[95%CI 1.29至5.39];p<0.05)。
  • 脂肪变性进展在撕裂扩大肩更常见(43%[45/105]比20%[10/51],p<0.05)。
  • 撕裂扩大且脂肪变性进展的肩更易延伸至冈上肌前部(53%比17%,p<0.05),但控制撕裂大小后该关系消失(p=0.56)。

关键数值与推荐

  • 从撕裂扩大至脂肪变性进展的中位时间:冈上肌1.0年(范围-2.0至6.9年),冈下肌1.1年(范围-1.8至8.5年)(p=0.98)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this prospective study was to examine the progression of fatty muscle degeneration over time in asymptomatic shoulders with degenerative rotator cuff tears. METHODS: Subjects with an asymptomatic rotator cuff tear in 1 shoulder and pain due to rotator cuff disease in the contralateral shoulder were enrolled in a prospective cohort. Subjects were followed annually with shoulder ultrasonography, which evaluated tear size, location, and fatty muscle degeneration. Tears that were either full-thickness at enrollment or progressed to a full-thickness defect during follow-up were examined. A minimum follow-up of 2 years was necessary for eligibility. RESULTS: One hundred and fifty-six shoulders with full-thickness rotator cuff tears were potentially eligible. Seventy shoulders had measurable fatty muscle degeneration of at least 1 rotator cuff muscle at some time point. Patients with fatty muscle degeneration in the shoulder were older than those without degeneration (mean, 65.8 years [95% confidence interval (CI), 64.0 to 67.6 years] compared with 61.0 years [95% CI, 59.1 to 62.9 years]; p < 0.05), and the median size of the tears at baseline was larger in shoulders with degeneration than in shoulders that did not develop degeneration (13 and 10 mm wide, respectively, and 13 and 10 mm long; p < 0.05). Tears with fatty muscle degeneration were more likely to have enlarged during follow-up than were tears that never developed muscle degeneration (79% compared with 58%; odds ratio, 2.64 [95% CI, 1.29 to 5.39]; p < 0.05). Progression of fatty muscle degeneration occurred more frequently in shoulders with tears that had enlarged (43%; 45 of 105) than in shoulders with tears that had not enlarged (20%; 10 of 51; p < 0.05). Additionally, tears with enlargement and progression of muscle degeneration were more likely to extend into the anterior supraspinatus than were those without progression (53% and 17%, respectively; p < 0.05); however, this relationship was lost when controlling for tear size (p = 0.56). The median time from tear enlargement to progression of fatty muscle degeneration was 1.0 year (range, -2.0 to 6.9 years) for the supraspinatus and 1.1 years (range, -1.8 to 8.5 years) for the infraspinatus muscle (p = 0.98). CONCLUSIONS: Progression of fatty muscle degeneration is more common in tears that are larger at baseline, enlarge over time, and undergo a larger magnitude of enlargement. Our study findings also suggest that an often rapid progression of muscle degeneration occurs in relation to a clinically relevant increase in tear size in some degenerative cuff tears. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Hebert-Davies J, Teefey SA, Steger-May K, et al. Progression of Fatty Muscle Degeneration in Atraumatic Rotator Cuff Tears. J Bone Joint Surg Am. 2017. PMID: 28509823. doi:10.2106/JBJS.16.00030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。